C3J Therapeutics, Inc. (C3J) a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials based on bacteriophage, today announced that the United... read more
C3J Therapeutics, Inc. (C3J) a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials based on bacteriophage, today announced that the United... read more
Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, have signed an agreement to establish a 50/50 joint venture to pioneer... read more
Just a month ago, Silk Road filed for its IPO with an expected maximum of $86 million. The company just amended the filing with a new expected maximum of $138 million. The company intends to trade... read more
Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, has completed a... read more
Enterome SA announced on 3/27/19 that it will present data on its innovative microbiome-based approach for the development of therapeutic peptide cancer vaccines for the first time in a poster at... read more
Genome editing company, Precision BioSciences, raised $126.4 million in its IPO on Wednesday. The company sold 7.9 million shares of stock at a public offering price of $16 per share. When it... read more
Orasis Pharmaceuticals LTD., a clinical stage pharmaceutical company developing a corrective eye drop for the treatment of presbyopia as an alternative to reading glasses, announced on 3/27/19 the... read more
NGM Updated its IPO filing to include an estimated price range of $14 to $16 per share. If all available shares are purchased, the IPO will raise more than $122 Million. The company intends to... read more
Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced on 3/25/19 that it has closed a $40 million financing with Perceptive Advisors. The new funding will... read more
Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today it has filed a registration... read more
Enterome SA announced on 3/20/19 that is has entered into a research and development collaboration with Dana-Farber Cancer Institute (Boston, MA) to evaluate and develop gut microbiome-derived... read more
Flagship Pioneering announced on 3/20/19 that it has secured $824 million in a new capital pool to support the growth of human health and sustainability companies originated by its Flagship Labs... read more
Download the full report here.
JD Supra just released its Life Sciences Report for Winter and... read more
miR Scientific LLC, a precision bioscience company focused on comprehensive disease detection and management, announced today a poster presentation at the 34th Annual European Association of... read more
Avantor Filed for a $100 million IPO on 3/15/19. The stock will trade on the NYSE under the symbol AVTR.
Avantor provides products and services to biopharma, nutraceutical, biomaterials... read more
Proteon Therapeutics, a clinical-stage company focused on first-in-class therapeutics that meaningfully improve the lives of patients with kidney and vascular diseases has filed for a $50 million... read more
